AVAI OTC
Avai Bio, Inc.
1W: +2.4%
1M: +8.2%
3M: +3.5%
YTD: -68.3%
1Y: -57.0%
3Y: -84.5%
5Y: -92.1%
$0.13
+0.01 (+6.30%)
Weekly Expected Move ±19.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$18.0M
52W Range0.101-0.8
Volume21,737
Avg Volume128,175
Beta0.87
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChris Winter
Employees1
SectorTechnology
IndustrySoftware - Application
IPO Date2020-04-06
Websiteavaibio.com
Sv. Stepono g. 27D-2
Vilnius, NV 89108
LT
Vilnius, NV 89108
LT
866 533 0065
About Avai Bio, Inc.
Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public. The company was established on November 6, 2017, and its main office is situated in Las Vegas, Nevada.
Latest News
Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
The Credibility Filter Wall Street Uses to Sort Biotech Winners
Recent Insider Trades
No insider trades found